IMO-8400, a toll-like receptor 7, 8, and 9 antagonist,...

  • Main
  • 2016 / 11
  • IMO-8400, a toll-like receptor 7, 8, and 9 antagonist,...

IMO-8400, a toll-like receptor 7, 8, and 9 antagonist, demonstrates clinical activity in a phase 2a, randomized, placebo-controlled trial in patients with moderate-to-severe plaque psoriasis

Balak, Deepak M.W., van Doorn, Martijn B.A., Arbeit, Robert D., Rijneveld, Rianne, Klaassen, Erica, Sullivan, Tim, Brevard, Julie, Bing Thio, H., Prens, Errol P., Burggraaf, J. (Koos), Rissmann, Rober
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Clinical Immunology
DOI:
10.1016/j.clim.2016.09.015
Date:
November, 2016
File:
PDF, 701 KB
english, 2016
Conversion to is in progress
Conversion to is failed